Related Experiment Video

Updated: Feb 8, 2026

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes
05:18

A Protocol for Constructing a Rat Wound Model of Type 1 Diabetes

Published on: February 17, 2023

5.9K

Challenges to Reshape the Future of Type 1 Diabetes Research

David Bleich1, David H Wagner2

  • 1Division of Endocrinology, Diabetes, & Metabolism, Rutgers New Jersey Medical School, Rutgers, The State University of New Jersey, Newark, New Jersey.

The Journal of Clinical Endocrinology and Metabolism
|June 19, 2018
PubMed
Abstract

Insights

Type 1 diabetes immunotherapy trials have failed for over 15 years. Future success requires precision medicine approaches that address individual patient differences and immunological complexities in clinical trial design.

Area of Science:

  • Immunology
  • Clinical Research
  • Precision Medicine

Background:

  • Immunotherapy trials aimed at preventing type 1 diabetes (T1D) have consistently failed for over 15 years.
  • A review of T1D research from 2000-2018 highlights persistent knowledge gaps in its immunology.
  • Understanding these gaps is crucial for developing more effective T1D prevention strategies.

Purpose of the Study:

  • To analyze the reasons for the failure of T1D immunotherapy trials.
  • To propose a new direction for T1D research focusing on precision medicine trial design.
  • To identify key immunological knowledge gaps that need to be addressed for future trial success.

Main Methods:

  • A review of high-quality, peer-reviewed basic science and clinical research trials for T1D.
  • Analysis of T1D publications from 2000 to 2018 using PubMed and Google Scholar databases.
  • Synthesis of immunological concepts and their integration with clinical trial design.

Main Results:

  • Uniform antigen-specific immunotherapy protocols have not prevented T1D.
  • Individual phenotypic and genotypic variations in patients are not adequately addressed in current trial designs.
  • Fundamental immunological aspects like disease stratification, individualized T cells, regulatory T-cell populations, and T-cell receptor rearrangement are critical knowledge gaps.

Conclusions:

  • Current immunotherapy approaches for T1D prevention are unlikely to succeed without addressing fundamental immunological principles.
  • Integrating personalized medicine strategies, considering individual patient variability, is essential for improving T1D trial outcomes.
  • Addressing identified knowledge gaps in T1D immunology will rectify clinical trial design and pave the way for future success.

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-1906:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

3.3K
Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.6K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
506
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.4K